DC Funds, LP
CIK 1869028
13F filing for Q2 2026・No. 2,215
- Holdings
- US$1.25B
- Quarter change
- −US$232.56M
- Entries
- 3
- Net bought (estimate)
- US$0
This quarter was filed in thousands of dollars (dollars are required since 2023); multiplied by 1,000 here.
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 0
- Sold out 0
- Cut 0
- Added 0
- Corporate actions 0
- Unchanged 3
Largest holdings
3 stocks worth US$1.25B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| TSCAN THERAPEUTICS INCCOM | Unchanged | 630,000 | US$617.46M | 49.27% |
| BARINTHUS BIOTHERAPEUTICS PLADS | Unchanged | 642,204 | US$423.86M | 33.82% |
| WEREWOLF THERAPEUTICS INCCOM | Unchanged | 589,102 | US$212.02M | 16.92% |
Sign in (free) to see its 3 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.